Introduction
Protein kinase C (PKC) plays a crucial role in transducing signals related to tumor promotion and suppression of apoptosis (Chen et al., 1998; Ruiz-Ruiz et al., 1999; Akkaraju and Basu, 2000; Basu et al., 2001; Shinohara et al., 2001; Trauzold et al., 2001; Guo and Xu, 2001) . Despite their importance, the downstream targets of PKC that mediate these actions are not known. Protein kinase D (PKD), a serine/threonine protein kinase with distinct structural, catalytic and regulatory properties (Johannes et al., 1994; Valverde et al., 1994) , is activated by a PKC-dependent signal transduction pathway involving phosphorylation of serines 744/748 in its activation loop (Iglesias et al., 1998; Waldron et al., 1999a Waldron et al., , 2001 ) and has thus emerged as a downstream eector of PKC (Matthews et al., 1997 (Matthews et al., , 2000 Waldron et al., 1999b Waldron et al., , 2001 Paolucci et al., 2000; Waldron and Rozengurt, 2000; Yuan et al., 2000; Zugaza et al., 1996 Zugaza et al., , 1997 .
PKD appears to have multiple functions, including potentiation of DNA synthesis and cell proliferation (Zhukova et al., 2001) , as well as suppression of epidermal growth factor (EGF) dependent c-Jun Nterminal kinase (JNK) activation (Bagowski et al., 1999) and c-Jun Ser 63 phosphorylation (Hurd and Rozengurt, 2001) . It also appears to suppress tumor necrosis factor (TNF) induced apoptosis . Because JNK phosphorylates c-Jun at Ser 63 and mediates apoptosis in response to stress signals and cytokines (Davis, 2000) , we considered the possibility that the inhibitory action of PKD toward JNK signaling is mediated by direct complex formation with JNK.
Here we demonstrate that mutational activation of PKD by substitution of constitutive negative charges at serines 744/748 or phosphorylation of PKD via PKC at these sites, results in molecular complex formation between PKD and JNK. Furthermore, we demonstrate that PKD phosphorylates sites in the cJun N-terminus distinct from those phosphorylated by JNK, suggesting that when PKD is activated through phosphorylation at Sers 744/748 in its activation loop via PKC it complexes with JNK and modulates the ability of JNK to phosphorylate c-Jun by phosphorylating distinct sites in the c-Jun N-terminus.
Results
Activated PKD co-immunoprecipitates with endogenous JNK2, but not ERK2, from HEK 293 cells Induced expression of PKD-S744/748E, under the control of a modi®ed ecdysone receptor responsive enhancer/promoter, suppresses EGF dependent c-Jun Ser 63 phosphorylation in clonal HEK 293 cells (Hurd and Rozengurt, 2001) . We used these cells to determine whether this active mutant of PKD forms a complex with JNK. Cells were treated with ponasterone-A for 22 h to induce PKD-S744/748E expression. PKD, JNK2 or ERK2 were immunoprecipitated, resolved by SDS ± PAGE, transferred and probed with anti-PKD (C-20) Ab (Figure 1a , upper panel) or anti-ERK2 Ab (lower panel). A band co-migrating with immunoprecipitated PKD was also immunoprecipitated by the JNK2 antibody. In contrast, it was absent from ERK2 immunoprecipitates, demonstrating the presence of PKD in JNK2, but not ERK2 immunocomplexes even though ERK2 was immunoprecipitated.
In order to determine whether the activation state of JNK aects complex formation with PKD-S744/748E, cells were treated with or without ponasterone-A for 22 h to induce expression of PKD-S744/748E and then with activators of JNK, including UV light or anisomycin A. JNK2 was immunoprecipitated and an in vitro kinase assay using GST-c-Jun (1 ± 89) as a substrate to detect JNK activity was performed ( Figure  1b) . Treatment with activators of JNK resulted in increased phosphorylation of GST-c-Jun (1 ± 89) indicating the presence of activated JNK. Furthermore, a band migrating at the expected molecular weight of PKD was detected. Its intensity depended on whether cells were treated with or without the inducer of PKD-S744/748E, indicating that inducible PKD-S744/748E that autophosphorylates also copuri®es with JNK in this assay. Substitution of anti-green¯uorescent protein (GFP) for anti-JNK2 in the immunoprecipitation and in vitro kinase assay resulted in loss of both JNK activity and the ponasterone-A inducible band, demonstrating that the epitope speci®city of the JNK2 antibody is required for co-immunoprecipitation of JNK activity and activated PKD.
The activation loop mutant, PKD S744/748E selectively co-immunoprecipitates with JNK PKD-S744/748E contains negative charges in its activation loop that mimic phosphorylation and activation by a PKC mediated pathway (Iglesias et al., 1998; Waldron et al., 1999a Waldron et al., , 2001 Hurd and Rozengurt, 2001 ). Substitution of asparagine for lysine at position 618 (PKD-K618N) prevents binding of ATP in the catalytic pocket and results in a kinase dead form of PKD (Zugaza et al., 1996; Hurd and Rozengurt, 2001; Waldron et al., 2001) .
We compared the ability of these mutants with that of wild-type PKD to co-immunoprecipitate with JNK ( Figure 2 ). COS cells were transiently co-transfected with the PKD constructs along with HA-JNK1 as indicated at the bottom of Figure 2 . HA-JNK1 was immunoprecipitated from cell lysates using an anti-HA Ab. Immunocomplexes (upper panels) and cell lysates (bottom panels) were resolved by SDS ± PAGE, transferred and probed for the presence of PKD and HA-JNK1 as indicated. Results show that PKD-S744/ S748E co-immunoprecipitates with HA-JNK1, whereas wild-type and kinase dead PKD did not, even though their expression levels in cell lysates are equivalent to that of cells transfected with PKD-S744/748E. Substitution of anti-pRB for anti-HA Ab during immunoprecipitation (see top of Figure 2 ) failed to immunoprecipitate either HA-JNK1 or PKD-S744/ S748E, even though they are present in lysates, showing anti-HA epitope speci®city for coimmunoprecipitation of PKD-S744/748E and HA-JNK1. Detection of PKD-S744/748E required transfection with both HA-JNK1 and PKD-S744/748E, since excluding either, resulted in a failure to coimmunoprecipitate Figure 1 (a) PKD-S744/748E immunoprecipitates with endogenous JNK2, but not ERK2. Clonal 293 cells which inducibly express PKD-S744/748E under the control of a modi®ed ecdysone receptor responsive enhancer promoter were treated with 1 mM ponasterone-A (ecdysone) for 22 h to induce PKD-S744/748E expression (Hurd and Rozengurt, 2001 ). Cells were lysed and PKD, JNK2 or ERK2 were immunoprecipitated, resolved by SDS ± PAGE, transferred and probed with anti-PKD/PKCm (C-20) (upper panel) or anti-ERK2 (C-14) (lower panel). (b) In vitro kinase assay of JNK2 immunocomplexes. Clonal 293 cells which inducibly express PKD-S744/748E were treated 22 h with (+) or without (7) 1 mM ponasterone-A and then with 3000 mJ6100 UV light (UV) or 10 mg/ml anisomycin (Anis.) and placed for 15 min in a cell incubator or maintained without treatment as a control (C). Cells were lysed and JNK2 was immunoprecipitated with anti-SAPK1/JNK (JNK2) and an in vitro kinase assay was performed. Alternatively, anti-green¯uorescent protein (GFP) was substituted for anti-JNK2 in the immunoprecipitation and in vitro kinase assay to demonstrate epitope speci®city of the JNK2 antibody to immunoprecipitate JNK and activated PKD. Proteins were resolved in 12% denaturing gels which were dried and exposed to X-ray ®lm to visualize bands PKD-S744/748E with anti HA antibody. These data demonstrate that exogenously expressed HA-JNK1 and PKD-S744/748E form a complex and substitution of serines 744 and 748 with glutamic acid stabilizes JNK-PKD complexes, however it does not exclude the possibility that other domains of PKD might also be involved. Figure 2 shows that wild-type PKD failed to coimmunoprecipitate with JNK whereas charges that mimic phosphorylation of PKD through a PKC mediated pathway, stabilize the complex. Because the novel PKC isoform PKCe, but not atypical PKCz has been shown to activate PKD via phosphorylation at Sers 744/748 in cotransfected COS cells (Iglesias et al., 1998; Waldron et al., 1999a Waldron et al., , 2001 , we triple transfected COS cells with HA-JNK1, wild-type PKD and either PKCe or PKCz (Figure 3a ). After transfection with the various expression plasmids as indicated at the top of the ®gure, HA-JNK1 was immunoprecipitated and the complexes were probed for the presence of PKD with a phosphorylation state independent anti-PKD antibody (C-20) (upper panel). Cell lysates were also probed for PKD activation loop phosphorylation (P-744/748) and expression levels of PKD and PKCs (lower panels).
Phosphorylation of PKD induced via PKCe triggers binding of PKD to JNK
Transfection with PKCe resulted in both phosphorylation of wild-type PKD at serines 744/748 and coimmunoprecipitation with JNK. COS cells express high levels of endogenous PKCz and transfection with exogenous PKCz only slightly increased its apparent expression levels in cell lysates. However, in spite of this, no phosphorylation or co-immunoprecipitation of wild-type PKD with JNK occurred, indicating, as previously demonstrated (Zugaza et al., 1996; Waldron et al., 1999b) , that this PKC isoform does not activate PKD through phosphorylation of its activation loop nor does it stabilize PKD-JNK complexes.
Activation loop phosphorylation of wild-type PKD stimulates its catalytic activity as measured by autophosphorylation or enhanced phosphorylation of exogenous substrate (Iglesias et al., 1998; Waldron et al., 1999a Waldron et al., , 2001 Hurd and Rozengurt, 2001) . To determine whether the catalytic activity of PKD is required for complex formation with JNK, we compared the ability of wild-type or kinase dead PKD to co-immunoprecipitate with JNK upon transfection with PKCe in COS cells (Figure 3b ). Similar to the previous experiment, when PKCe was included in the transfection, both wild-type and kinase dead PKD were phosphorylated in the activation loop and the quantity of both forms of PKD coimmunoprecipitating with JNK was drastically increased. These data indicate that PKD-JNK complex formation is independent of PKD catalytic activity, but is determined by PKC mediated phosphorylation of its activation loop.
Catalytically active PKD phosphorylates the c-Jun N-terminus in vitro
The eciency of c-Jun phosphorylation by JNK is dependent on its ability to complex with the delta domain in the N-terminus of c-Jun (Kallunki et al., 1994 (Kallunki et al., , 1996 Gupta et al., 1996; Tanoue et al., 2000; Davis, 2000) . The N-terminus of c-Jun contains numerous serines and threonines that PKD could potentially phosphorylate. We thus considered the possibility that catalytically active PKD complexed with JNK could interfere with JNK phosphorylation of c-Jun at Ser 63 by phosphorylating alternative sites in the c-Jun N-terminus.
To determine whether PKD phosphorylates c-Jun we assessed the ability of wild-type PKD, isolated from transiently transfected COS cells, to phosphorylate GST-c-Jun (1 ± 89). COS cells were transiently transfected with wild-type PKD. After transfection, the cells were treated with or without 200 nM phorbol 12, 13-dibutyrate (PDB) for 15 min to activate PKD. PKD was immunoprecipitated and an in vitro kinase assay performed. As shown in Figure 4a , PDB treatment of COS cells resulted in activation of PKD as shown by increased autophosphorylation as well as enhanced phosphorylation of GST-c-Jun (1 ± 89).
We next examined whether immunoprecipitates of constitutively active PKD-S744/748E or kinase dead PKD-K618N could phosphorylate GST-c-Jun (1 ± 89). Clonal HEK 293 cells that inducibly express PKD-S744/748E or PKD-K618N were treated with ponasterone-A for 22 h to induce either mutant form of PKD. PKD was immunoprecipitated with C-20 anti-PKD Ab and an in vitro kinase assay was performed using GST-c-Jun (1 ± 89) as the substrate. Figure 4b shows PKD immunoprecipitated from cells expressing PKD-S744/748E phosphorylated GST-c-Jun (1 ± 89) to a greater extent than immunoprecipitates of PKD-K618N. Under inducible expression conditions utilized in this experiment, the levels of PKD in either clone are approximately equal (Hurd and Rozengurt, 2001 ). Thus, these data indicate that the constitutive negative charges in the activation loop of PKD-S744/748E besides enhancing complex formation with JNK account for phosphorylation of GST-c-Jun (1 ± 89) and that it is not the result of coimmunoprecipitating kinases.
To con®rm that PKD phosphorylates sites in the c-Jun portion of the GST-c-Jun (1 ± 89) fusion protein, highly puri®ed human PKD was combined in an vitro reaction with GST or GST-c-Jun (1 ± 89). Figure 4c shows that PKD phosphorylates GST-c-Jun (1 ± 89), but not GST, demonstrating that PKD phosphorylates sites on the cJun sequences between amino acids 1 ± 89.
PKD phosphorylates sites in the c-Jun N-terminus distinct from JNK phosphorylation sites
We performed two-dimensional tryptic phosphopeptide mapping of the GST-c-Jun (1 ± 89) substrate after phosphorylation with either puri®ed PKD or JNK to determine whether PKD phosphorylates sites distinct from those phosphorylated by JNK ( Figure 5 ). Wildtype HEK 293 cells were subjected to UV light to maximally activate JNK. JNK was immunoprecipitated and used to phosphorylate GST-c-Jun (1 ± 89) in vitro. Alternatively, GST-c-Jun was phosphorylated by puri®ed PKD. Phosphorylated GST-c-Jun (1 ± 89) was resolved by SDS ± PAGE, excised and trypsinized. Trypsinized phosphopeptides phosphorylated by JNK (A) or PKD (B) were resolved individually or when mixed together (A+B) as indicated in the Figure. Immunoprecipitated JNK phosphorylated two distinct peptides (1 and 2) previously shown to be on c-Jun tryptic peptides containing Ser 73 (circled) and 63 (arrow) respectively (Smeal et al., 1991) . In contrast, PKD phosphorylated 4 peptides (2, 3, 4 and 5) only one of which (peptide 2) co-resolved with a JNK speci®c peptide when samples were mixed (A+B). Three others (3, 4 and 5), containing the 
Discussion
The fact that PKD-S744/748E co-immunoprecipitates with endogenous JNK2 from HEK293 cells or with exogenously expressed HA-JNK1 from transfected COS cells, indicates the general nature of the PKD-JNK interaction. Furthermore, we show a strong correlation between activation loop phosphorylation of PKD at serines 744/748 and its ability to complex with JNK. We can not exclude the possibility that contacts between JNK, PKD and PKCe, independently of phosphorylation of PKD, enhance the ability of PKD to co-immunoprecipitate with JNK. However, the fact that the PKD-S744/S748E mutant, which mimics phosphorylation of these same sites by a PKC mediated pathway, co-immunoprecipitates with JNK in the absence of PKCe transfection (see Figure  2) , strongly indicates that phosphorylation of these sites on wild-type PKD triggers complex formation with JNK.
PKD has been shown to complex with a number of other proteins including PKCZ (Waldron et al., 1999b ), 14-3-3 , the B-cell receptor complex (Sidorenko et al., 1996) , paxillin (Bowden et al., 1999) , phosphatidylinositol 4-kinase and phosphatidylinositol-4-phosphate 5-kinase (Nishikawa et al., 1998 ), Bruton's tyrosine kinase , kidins220 (Iglesias et al., 2000) and the multifunctional chaperone protein p32 (Storz et al., 2000) . In some cases discrete domains of PKD have been implicated in mediating complex formation (Waldron et al., 1999b; Hausser et al., 1999; Storz et al., 2000) . However, the results presented here provide the ®rst demonstration that PKD interacts with another signaling molecule in a phosphorylation dependent manner.
The kinase activity of PKD is apparently not required for complex formation with JNK, since wild-type PKD which is catalytically activated by cotransfection with PKCe (Iglesias et al., 1998; Waldron et al., 1999a Waldron et al., , 2001 , co-immunoprecipitates with JNK equivalently to kinase dead PKD. This indicates that association of PKD and JNK is determined upstream of PKD catalytic activation through phosphorylation of its activation loop by a PKC mediated pathway. Thus, although JNK-PKD-K618N complex formation can be induced by activation loop phosphorylation it would be incapable of further signaling that depends on the kinase activity of PKD. In contrast, activation loop phosphorylation of wild-type PKD or expression of PKD-S744/748E which mimics phosphorylation of these sites by a PKC mediated pathway retain both the ability to complex with JNK and phosphorylate substrates downstream of this complex formation.
PKD has been shown to suppress EGF dependent cJun phosphorylation at Ser 63 (Hurd and Rozengurt, 2001) , however the precise mechanism involved is not understood. Our demonstration that PKD phosphorylates sites in the c-Jun N-terminus which are distinct from the known phosphorylation sites of JNK suggests an intriguing possibility. When PKD is phosphorylated in its activation loop by a PKC mediated pathway and is thus catalytically activated and associates with JNK, it impairs the ability of JNK to phosphorylate c-Jun by phosphorylating alternative sites in the c-Jun Nterminus.
Materials and methods

Reagents
The ecdysone inducible expression kit, EcR293 cells, pINDsp1 plasmid, ponasterone-A, hygromycin-B and zeocin were purchased from In Vitrogen. PKCm/PKD (C-20), ERK2 (C-14), nPKCe (C-15), nPKCZ (C-15), nPKCz (C-20) and HA-probe (F-7) antibodies were from Santa Cruz Biotechnology. The Anti-SAPK1/JNK (JNK2) antibody was from Upstate Biotechnology. Anisomycin was from Sigma. Phospho-PKD/PKCm (Ser 744/748) antibody and the c-Jun (1 ± 89) fusion protein were from Cell Signaling Technology. Human recombinant protein kinase D was purchased from Calbiochem. 
Cell culture and treatment of cells
Generation and maintenance of clones inducibly expressing PKD-S744/748E or PKD-K618N have been described previously (Hurd and Rozengurt, 2001) . For activation of JNK, cells in media, with tops of plates removed, were subjected to 3000 mJ 6100 UV light in a Stratalinker 1800 or treated with 10 mg/ml of media with anisomycin and then placed in cell incubator for 15 min prior to cell lysis. To activate PKD, transfected COS cells were treated with 200 nM PDB for 15 min.
Transient transfection of Cos-7 cells
Cells were cultured to 40% con¯uency on 100 mm plates and then transfected using lipofectin reagent according to instructions from Gibco-BRL. This involved dissolving a total of 12 ± 18 mg of DNA or 20 mL lipofectin reagent separately in 660 mL Opti-mem with incubation at room temperature for 45 min. Solutions were combined and incubated for 15 min to form lipofectin-DNA complexes prior to the addition of 4 ml Opti-mem to the mixture. The entire mixture was then layered onto pre-washed cells (twice with 5 ml Opti-mem) and cells were incubated at 378C for 18 h at a 5% CO 2 pressure. Cells were recovered in 10 ml of culture media containing 10% FBS for 2 days prior to cell lysis.
Immunoprecipitation
All procedures were conducted at 0 ± 48C unless stated otherwise. Media was aspirated from the cells cultured on 100 mm plates, washed twice with 5 ml of ice cold PBS and then lysed for 5 min on ice in 1 ml of cell lysis buer (20 mM HEPES, pH 7.4, 150 mM NaCl, 10 mM sodium pyrophosphate, 2 mM sodium ortho vanadate, 10 mM NaF, 10% glycerol, 1 mM EDTA, 1% Triton X-100, 1 mM AEBSF, 10 mg/ml leupeptin, 10 mg/ml aprotinin). Lysate was clari®ed by centrifugation at 15 000 r.p.m. for 10 min in a mcentrifuge. PKD, HA-JNK 1 or JNK 2 were immunoprecipitated with 4 mg of PKCm/PKD (C-20), HA probe (F7) or Anti-SAPK1/JNK (JNK2) per 1 ml of clari®ed cell lysate and a 50 : 50 suspension of protein-A agarose. Immunoprecipitates were mixed for 2 h and then washed ®ve times with 1 ml of lysis buer. Immunoprecipitates were then used for in vitro kinase assays or denatured for Western blot analyses as described below.
In vitro kinase assay JNK2 or PKD were immunoprecipitated as stated above. After washing in cell lysis buer, the pellets were washed a ®nal time in 1 ml kinase assay buer (20 mM HEPES, pH 7.5, 10 mM magnesium chloride, 2 mM dithiothreitol, 0.2 mM sodium orthovanadate). Pellets were incubated 20 min at 308C in 30 ml kinase assay buer containing a ®nal concentration of 50 mM ATP, 5 mCi [g-32 P]ATP and 3 mg c-Jun 1 ± 89 GST fusion protein per reaction. Proteins were denatured with 100 ml SDS ± PAGE sample buer, resolve in 12% denaturing gels which were dried and exposed to X-ray ®lm to visualize bands.
Phosphopeptide mapping
Wild-type 293 cells were subjected to UV light, JNK2 was immunoprecipitated and an in vitro kinase assay performed as stated above. Alternatively, puri®ed PKD (0.5 mg) was combined with 30 ml kinase assay buer and a ®nal concentration of 50 mM ATP, 5 mCi [g-32 P]ATP and 3 mg c-Jun 1 ± 89 GST fusion protein per reaction. Reactions were incubated 20 min at 308C, denatured and resolved by 12% SDS ± PAGE. The phosphorylated GST-c-Jun (1 ± 89) band was excised from dried gels and processed for tryptic two-dimensional phosphopeptide mapping as previously described (Iglesias et al., 1998) . Half the quantity of radioactivity (approximately 2000 c.p.m.) from either reaction was resolved independently or when mixed together. Thin layer electrophoresis in pH 1.9 buer (2.2% formic acid 7.8% acetic acid) was performed for 30 min at a constant current of 20 mA. The solvent system for ascending chromatography consisted of n-butanol, pyridine, acetic acid and water at a ratio of 75 : 50 : 15 : 60. Thin layer plates were air dried and exposed to X-ray ®lm to visualize radiolabeled peptides.
Western blot analysis
Proteins were resolved by 8% SDS ± PAGE, transferred to immobilon-P membranes at 400 mA for 4 h at 48C in transfer buer (25 mM Tris-base, 200 mM glycine, 20% methanol and 0.033% SDS). Membranes were blocked 1 h in PBS-tween (0.1%) plus 5% dry milk and then probed overnight with a 1 : 1000 dilution of primary antibody in PBS-tween plus 3% dry milk. Membranes were washed three times in PBS-tween and then probed with a 1 : 2000 dilution of HRP-conjugated anti-rabbit or mouse IgG secondary antibody in PBS-tween plus 3% dry milk for 1 h. Membranes were washed three times for 15 min and bands visualized by enhanced chemiluminescence according to manufacturer's instructions.
